Key Record Dates
ClinicalTrials.gov Identifier: | NCT04137900 |
---|---|
Brief Title: | Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies |
First Submitted : | October 21, 2019 |
First Submitted that Met QC Criteria : | October 22, 2019 |
First Posted : | October 24, 2019 |
Last Update Submitted that Met QC Criteria : | May 3, 2023 |
Last Update Posted : | May 6, 2023 |